Generic Drug Service, Not Pricing, Is Key Performance Factor – Lehman’s Silver

The success of generic companies will be determined more by the breadth and quality of their offerings than product pricing, Lehman Brothers Senior VP-Specialty Pharmaceutical Research Rich Silver told the Generic Pharmaceutical Association